{
    "data": [
        {
            "id": "2755965",
            "type": "article",
            "attributes": {
                "publishOn": "2014-12-16T10:32:16-05:00",
                "isLockedPro": false,
                "commentCount": 49,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "2 Large Blood Testing Companies Stand To Be Disrupted",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "25047",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3302",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2755965-2-large-blood-testing-companies-stand-to-be-disrupted"
            }
        },
        {
            "id": "2487735",
            "type": "article",
            "attributes": {
                "publishOn": "2014-09-11T10:50:30-04:00",
                "isLockedPro": false,
                "commentCount": 2,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Quest Diagnostics Offers A Good Long-Term Opportunity",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "24580",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "140618",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3302",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/2487735-quest-diagnostics-offers-a-good-long-term-opportunity"
            }
        },
        {
            "id": "2282823",
            "type": "article",
            "attributes": {
                "publishOn": "2014-06-23T19:56:16-04:00",
                "isLockedPro": false,
                "commentCount": 5,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Bloody Disruption: New Threat To Quest, LabCorp",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "23478",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3302",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2282823-bloody-disruption-new-threat-to-quest-labcorp"
            }
        },
        {
            "id": "2240633",
            "type": "article",
            "attributes": {
                "publishOn": "2014-05-28T05:56:50-04:00",
                "isLockedPro": false,
                "commentCount": 2,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "The Best Dividend Growers, Part 15: Quest Diagnostics",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "52212",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3302",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2240633-the-best-dividend-growers-part-15-quest-diagnostics"
            }
        },
        {
            "id": "2086243",
            "type": "article",
            "attributes": {
                "publishOn": "2014-03-13T09:39:39-04:00",
                "isLockedPro": false,
                "commentCount": 3,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Quest Diagnostics Has An Improved Outlook After Summit Health Acquisition And $600 Million Refinancing",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "27731",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "130790",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3302",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2086243-quest-diagnostics-has-an-improved-outlook-after-summit-health-acquisition-and-600-million-refinancing"
            }
        }
    ]
}